Welcome to LookChem.com Sign In|Join Free
  • or
1-Octyn-4-ol, benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61284-53-5

Post Buying Request

61284-53-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61284-53-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61284-53-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,2,8 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 61284-53:
(7*6)+(6*1)+(5*2)+(4*8)+(3*4)+(2*5)+(1*3)=115
115 % 10 = 5
So 61284-53-5 is a valid CAS Registry Number.

61284-53-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name benzoic acid,oct-1-yn-4-ol

1.2 Other means of identification

Product number -
Other names 4-Benzyloxy-1-octin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61284-53-5 SDS

61284-53-5Relevant academic research and scientific papers

Vinylstannyl derivatives

-

, (2008/06/13)

Vinylstannyl derivatives and the processes for their conversion to vinyliodides, vinylbromides and vinyllithium reagents. The vinylstannyl, vinyliodides, vinylbromide derivatives and vinyllithiums are useful as intermediates for the preparation of prostaglandin analogs.

1-Hydroxymethyl-1-1-oxo prostane derivatives of the E and F series

-

, (2008/06/13)

The invention disclosed herein relates to pharmacologically active prostaglandin derivatives of the E, F, or A series having on the terminal methylene carbon of the alpha chain a substituent selected from the group consisting of: STR1 wherein R is an alkyl group and R15 is C1 -C4 alkyl, C1 -C4 alkoxy, di-C1 -C4 -alkylamino, and phenyl orphenyl substituted with one or more substituents selected from the group consisting of C1 -C4 alkyl, OR, SR, F, or Cl wherein R is as previously defined.

1-Substituted-1-oxo-prostane-derivatives of the E, A and F series

-

, (2008/06/13)

The invention disclosed herein relates to pharmacologically active prostaglandin derivatives of the E, F, or A series having on the terminal methylene carbon of the alpha chain, a substituent selected from the group consisting of: STR1 wherein R is C1 to C6 alkyl, and phenyl or phenyl substituted with one or more substituents selected from the group consisting of C1 -C4 alkyl, OR16, SR16, F, or Cl, and R16 is C1 to C6 alkyl.

11-(2-Hydroxyethylthio) prostenoic acid E and F series derivatives

-

, (2008/06/13)

This disclosure describes certain 11-(2-hydroxyethylthio) prostenoic acid E and F series derivatives, and their intermediates, useful as bronchodilators and inflammatory medeator release inhibitors.

Novel vinyl-stannyl derivatives

-

, (2008/06/13)

Vinylstannyl derivatives and the processes for their conversion to vinyliodides, vinylbromides and vinyllithium reagents. The vinylstannyl, vinyliodides, vinylbromide derivatives and vinyllithiums are useful as intermediates for the preparation of prostaglandin analogs.

1-Hydroxymethyl-1-oxo-prostane derivatives of the E2 series

-

, (2008/06/13)

Derivatives, analogs, and congeners of prostane having a 1-(hydroxymethyl)-1-oxo-prostane structure in the E2 series.

11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives

-

, (2008/06/13)

This disclosure describes certain 11-(2-hydroxyethylthio)-9-keto-prostenoic acid E series derivatives, and their intermediates, useful as bronchodilators and inflammatory medeator release inhibitors.

Novel 16 hydroxy 15-deoxy-5-cis-prostenoic acids and esters

-

, (2008/06/13)

This disclosure describes certain hydroxy substituted 15-deoxy-5-cis-prostenoic acids and esters useful as hypotensive agents, anti-ulcer agents, bronchodilators, anti-microbial agents, anticonvulsants, or as intermediates.

Derivatives of 9-hydroxy-13-trans-prostenoic acid

-

, (2008/06/13)

This disclosure describes certain 15-deoxy prostanoic acid derivatives having a hydroxy group further along in the beta-chain, useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

Hydroxylated 15-deoxy derivatives of 9-hydroxy-13-trans-prostenoic acid

-

, (2008/06/13)

This disclosure describes certain 15-deoxy prostanoic acid derivatives having a hydroxy group further along in the beta-chain, useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61284-53-5